<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00918437</url>
  </required_header>
  <id_info>
    <org_study_id>OES-002</org_study_id>
    <nct_id>NCT00918437</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Course After Uvulopalatoplasty</brief_title>
  <official_title>Characterization of the Postoperative Pain Course and Intensity After Uvulopalatoplasty With Radiofrequency Knife (RAUP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the postoperative course including effects on the&#xD;
      quality of life following soft palate surgery with radiofrequency knife (RAUP).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the treatment of social snoring one common treatment modality is the surgical&#xD;
      reconstruction of the soft palate. The procedure is a routine operation performed at nearly&#xD;
      all Ear-Nose- and Throat departments in Norway. The surgery is done with local anaesthesia in&#xD;
      an out-patient setting where the patients' postoperative observation at the hospital is&#xD;
      limited to 1-2 hours. As the surgery is done in the sensitive mucosa and palatopharyngeal&#xD;
      musculature the postoperative course might be unpleasant. The patients are therefore in the&#xD;
      need of regular postoperative pain treatment extending into the 2 first weeks after surgery.&#xD;
&#xD;
      At hospitals the uvulopalatoplasty is performed using a radiofrequency knife (RAUP) after the&#xD;
      soft palate has been infiltrated with local anaesthesia (1% xylocain/adrenaline). The&#xD;
      incision is done paramedialy to the uvular base and up into the musculature of the soft&#xD;
      palate then making a smooth arch toward the pharyngeal tonsil upper limit. The then elongated&#xD;
      uvula is amputated to about ½ cm. Occasionally, a suture is placed laterally and medially to&#xD;
      lift the palate and prevent postoperative scaring. Coagulation is done if necessary with&#xD;
      light bipolar diathermy.&#xD;
&#xD;
      As the postoperative course might be unpleasant after RAUP it is of interest to study the&#xD;
      time course and intensity of pain after surgery when using the standardised postoperative&#xD;
      pain treatment at OmniaSykehuset. The result will be useful in future studies looking at ways&#xD;
      to improve the pain treatment after uvulopalatoplasty.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity 0-10 Numerical Rating Scale</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Norwegian McGill Pain Questionnaire (NMPQ)</measure>
    <time_frame>14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Norwegian Translated Short-Form McGill Pain Questionnaire (NTSF-MPQ)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Health Impact Profile (OHIP-14)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corahs Dental Anxiety Scale (CDAS)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">33</enrollment>
  <condition>Snoring</condition>
  <condition>Surgical Procedures, Operative</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>RAUP treatment</arm_group_label>
    <description>Patients referred to the hospital for a snoring problem</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of either sex, of Caucasian origin, between the age of 18 and 80, who are referred&#xD;
        to the hospital for snoring that have been subjected to a sleep study indicating that&#xD;
        uvulopalatoplasty might have a considerable affect on the snoring.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients of either sex of Caucasian origin who are referred to the hospital for&#xD;
             snoring that have been subjected to a sleep study indicating that uvulopalatoplasty&#xD;
             might have a considerable affect on the snoring.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic drug treatment (except birth control medication) with analgesics,&#xD;
             anti-inflammatory treatment (both steroidal (SAIDs) and non-steroidal&#xD;
             anti-inflammatory drugs (NSAIDs)) apart from standard postoperative analgesic&#xD;
             treatment administered by the operator.&#xD;
&#xD;
          -  Patients with diabetes.&#xD;
&#xD;
          -  Patients who due to age or communication skills are considered unable to complete&#xD;
             patient forms.&#xD;
&#xD;
          -  Professional evaluation suggests an alteration of the planned surgical area or&#xD;
             treatment form.&#xD;
&#xD;
          -  Known or assumed intolerance or hyper sensibility to diclofenac, codeine or&#xD;
             paracetamol (standard postoperative analgesic treatment).&#xD;
&#xD;
          -  Consumption of alcohol in the period from 2 days before or until the end of the&#xD;
             primary observation period (postoperative days 0-7&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Øystein S Eskeland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lasse A Skoglund, DDS, DSci</last_name>
    <role>Study Chair</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Per Skjelbred, MD, DDS</last_name>
    <role>Study Director</role>
    <affiliation>Ullevaal University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aleris Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>NO-0264</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975 Sep;1(3):277-299. doi: 10.1016/0304-3959(75)90044-5.</citation>
    <PMID>1235985</PMID>
  </reference>
  <reference>
    <citation>Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987 Aug;30(2):191-197. doi: 10.1016/0304-3959(87)91074-8.</citation>
    <PMID>3670870</PMID>
  </reference>
  <reference>
    <citation>Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997 Aug;25(4):284-90.</citation>
    <PMID>9332805</PMID>
  </reference>
  <reference>
    <citation>Corah NL. Dental anxiety. Assessment, reduction and increasing patient satisfaction. Dent Clin North Am. 1988 Oct;32(4):779-90. Review.</citation>
    <PMID>3053270</PMID>
  </reference>
  <reference>
    <citation>Kim HS, Schwartz-Barcott D, Holter IM, Lorensen M. Developing a translation of the McGill pain questionnaire for cross-cultural comparison: an example from Norway. J Adv Nurs. 1995 Mar;21(3):421-6.</citation>
    <PMID>7745193</PMID>
  </reference>
  <verification_date>June 2005</verification_date>
  <study_first_submitted>June 9, 2009</study_first_submitted>
  <study_first_submitted_qc>June 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2009</study_first_posted>
  <last_update_submitted>July 3, 2011</last_update_submitted>
  <last_update_submitted_qc>July 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Professor Lasse A. Skoglund</name_title>
    <organization>Section of Dental Pharmacology and Pharmacotherapy, University Of Oslo</organization>
  </responsible_party>
  <keyword>uvulopalatoplasty</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Snoring</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

